Fake Veterinary Drugs Supplied in UP, Probe Ordered

Written By :  Parthika Patel
Published On 2026-02-17 18:16 GMT   |   Update On 2026-02-17 18:16 GMT
Advertisement

Lucknow: A major quality lapse has come to light in Uttar Pradesh after deworming medicines supplied to the State Animal Husbandry Department were found to be fake and not meeting prescribed standards. Authorities have immediately stopped further distribution of the affected batch and initiated steps to blacklist the supplier.

The medicines involved, Fenbendazole IP 1000 mg and Niclosamide IP 1500 mg, had been distributed to multiple districts as part of routine livestock deworming drives. Concerns were raised after field reports indicated that the drugs were not delivering expected results. Acting on these complaints, officials collected samples from a batch identified as EMVB-24296 and sent them for laboratory analysis in Agra.

Advertisement

Test results confirmed that the medicines failed to comply with required quality parameters, prompting swift administrative action. The Animal Husbandry Department directed all district veterinary offices to immediately stop using the specified lot and return any remaining stock to the polyclinic superintendent in Lucknow.

Deworming treatments are typically administered to livestock twice annually to prevent parasitic infections and maintain animal health. Experts warn that ineffective or counterfeit drugs can adversely affect cattle and other livestock, potentially leading to reduced productivity and financial setbacks for farmers reliant on dairy and meat production.

The consignment had reportedly been supplied by a pharmaceutical firm based in Sirmaur, Himachal Pradesh. Following the laboratory findings, departmental authorities have begun proceedings to blacklist the company and launched a detailed inquiry into the procurement and supply chain process. According to a recent media report in The420.in, the department is also examining possible lapses in verification mechanisms that allowed the batch to be cleared for distribution.

Officials are reviewing existing quality control protocols and considering stricter pre-dispatch testing measures to prevent recurrence of such incidents. The case has sparked concerns over monitoring standards in government veterinary medicine procurement and distribution systems.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News